AzTrials
AzTrials

CataractVBOBNCT06551480

VCSEL Based Optical Swept Source Biometry

A study testing Biometry in people with Cataract and Myopia, run by Rainer Leitgeb at 1 site in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Optical interferometric biometry is a non-invasive and highly precise method for measuring eye length and intraocular distances. The method already exists as commercial devices (e.g. IOLMaster, Carl Zeiss Meditec AG). A major cost factor of the devices available on the market is the laser used. Read more about this study

Who is it for?
Ages 19 to 95 yearsHealthy volunteers can take part
Conditions the study is for
Cataract, Myopia
What is being tested?
Biometry
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteAustria
Study dates
27 Aug 2021to 1 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 95 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • healthy participants
  • cataract patients (LOCS III grading)
  • written informed consent

Who cannot join

  • corneal pathology that would significantly influence biometric measurements
  • pathologies that could affect fixation abilities other than cataract
  • pregnancy (for women in reproductive age a pregnancy test will be performed)

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Medical University of Vienna

    Vienna, 1090

Other trials in Austria

About this study

Official title: Pilot Study on VCSEL-based Optical Swept Source Biometry

Optical interferometric biometry is a non-invasive and highly precise method for measuring eye length and intraocular distances. The method already exists as commercial devices (e.g. IOLMaster, Carl Zeiss Meditec AG). A major cost factor of the devices available on the market is the laser used. The use of a much cheaper laser could significantly reduce the price of these devices, which would lead to greater availability of this technology in developing countries. This would make it possible to replace the ultrasound methods used to date and thus enable contact-free measurements, which in turn can reduce the spread of infectious diseases.The study investigates the use of a thermally tunable vertical cavity surface emitting laser (VCSEL) for optical swept source biometry.

Read the detailed description
  1. Background With 15 million operations per year, cataract surgery is the most commonly performed eye surgery. The number of operations worldwide is expected to increase by 25% between 2008 and 2015. The simplest operation is the implantation of a monofocal intraocular lens (IOL). It is the most commonly performed cataract procedure in developing countries (e.g. 65% in India), as well as in rural and poor areas in industrialized countries. To prepare for the operation, simple IOL calculation formulas are used that require knowledge of the axial eye length. Today, biometry is mainly performed by applanation ultrasound and simple keratometers. However, optical measurement by low coherence interferometry (OCT) is becoming increasingly important, as it has the important advantage of being contact-free and thus avoiding complications that can be caused by possible infections. In addition, the method is extremely precise and does not depend on the skill of the doctor. A major cost factor in the production of such devices is the laser used. The use of a much cheaper laser diode could significantly reduce the price, which would ensure availability even in developing countries.
  2. Rationale The suitability of electrically tuned VCSEL laser diodes as light sources for determining intraocular distances is to be investigated. The results are to be compared with those of a commercial device in terms of signal quality and measurement accuracy. Such a device would be contact-free, which would help prevent infections, would be significantly cheaper than currently available methods, and would be able to determine intraocular distances very precisely.
  3. Study objectives The aim of the study is to demonstrate the usability of an electrically tuned VCSEL laser diode as a cost-effective alternative to the lasers used to date. To this end, the precision, reproducibility and manageability of the measurement with the VCSEL laser diode will be investigated. Test subjects and cataract patients will be examined. The precision of the measurement with the device of intraocular distances will be compared with that of a commercial device, IOLMaster500 from Carl Zeiss Meditec.
  4. Study Design

The study is a pilot study. It takes the measurement principle of a commercially available device for measuring eye length as a starting point.

The technology used is swept source Optical Coherence Tomography. This swept source is to be implemented using the electrically tuned VCSEL laser diode. Such laser diodes are able to change their central wavelength by changing the driver current. Another advantage arises from the VCSEL technology used in the laser diode used. This type of laser diode has a very narrow instantaneous line width and thus a very long coherence length, which far exceeds that required for the biometry of the eye.

In swept source OCT, the attenuation of the signal in depth is much lower than in spectrometer-based systems. In addition, the sensitivity is higher than with time-domain partial coherence interferometry (PCI) biometry systems and they are much faster. The reason is that the entire axial structure is encoded in parallel in the spectrum.

4.1. Implementation and evaluation: In the proposed study, intraocular distances, primarily the axial eye length and the anterior chamber depth, of the participating subjects and patients are to be determined using the method described. This is an exploratory pilot study to determine whether the VCSEL-based technology is suitable (in terms of speed of measurement and sensitivity of the method) to achieve a precise determination of the axial eye length in both healthy subjects and cataract patients with various degrees of cataract. The measurements with the IOLMaster serve as a basis for comparison.

Participants in the study are to be healthy subjects and cataract patients. All participants will first undergo a routine examination. Other risks will also be identified during the routine examination. These examinations will be carried out at the Eye Clinic.

The test subjects and patients are then measured using the measurement setup at the Center for Medical Physics and Biomedical Engineering.

The routine examination at the eye clinic includes a slit lamp and eye length measurement. The eye to be examined is selected by the investigator during the routine examination.

4.2 Selection of the study population The participants are recruited via public notices. 30 healthy subjects are selected between the ages of 19 and 85 years. 30 cataract patients are selected between the ages of 19 and 85 years .

4.3 Preliminary examination:

  • Routine examination at the Eye Clinic of the Medical University of Vienna. - - Measurement of eye length using IOL Masters.
  • For cataract patients, the degree of cataract is determined based on the Lens Opacities Classification Systems (LOCS III)

4.4. Withdrawal or replacement of study participants

The study participants will be excluded from the study under the following circumstances:

  • If they so wish
  • If the study director believes that the study is not in the interest of the study participant
  • If the study participant violates one of the requirements and points of the consent form In any case, the study exclusion will be recorded with a detailed explanation. If the study has to be terminated, the data will be retained.

Study participants who cannot complete the study will be replaced. The data can, however, be used for analysis.

4.5. Target variables

Axial eye length and anterior chamber depth: standard deviation and mean over repeated measurements will be analyzed; A comparison with the reference device will be established through Bland-Altman analysis.

Measurements are taken per study participant with IOL Master (Carl Zeiss Meditec AG) and measurement setup with current tuned VCSEL diode

Conditions
Cataract, Myopia
Being tested
Biometry
Medical subject headings
Cataract, Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BiometryDevice

    Only one eye from each patient will be included in the study. All subjects and patients included in the study will undergo biometric measurements with both devices (IOL master 500 and VCSEL based swept source optical biometry).

Study groups in NCT06551480
Study groupRoleWhat they receive
Pilot StudyExperimentalPilot study in healthy participants and cataract patients
Receives: Device: Biometry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. axial length

    limits of agreement between the optical biometers (mm)

    Measured: 1 day

  2. anterior chamber depth

    limits of agreement between the optical biometers (mm)

    Measured: 1 day

Secondary outcomes (1)
  1. intraocular distances

    repeatability on the VCSEL swept source biometer for axial length, anterior chamber depth, corneal thickness, and lens thickness

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2024
  2. Study start27 Aug 2021
  3. Primary completion1 Feb 2024
  4. Study completion1 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06551480
Sponsor's protocol ID
MUW_VBOB
Acronym
VBOB
Status last verified
Aug 2024
First submitted
9 Aug 2024
Last updated
13 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All results will be shared in a published paper.

Questions about this trial

What is this clinical trial studying?

A study testing Biometry in people with Cataract and Myopia, run by Rainer Leitgeb at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

axial length (time frame: 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2024; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in